Copyright ©The Author(s) 2017.
World J Hematol. Aug 6, 2017; 6(3): 32-54
Published online Aug 6, 2017. doi: 10.5315/wjh.v6.i3.32
Figure 19
Figure 19 Dual clopidogrel and coumarin compared to triple clopidogrel coumarin and aspirin in 573 patients undergoing PCI receiving oral anticoagulation for another reason in the WOEST study was equal in terms of death, reoclusion and revascularization but superior for dual clopidogrel/coumarin in terms of any bleeding (44. 4% vs 19.4%), major and minor bleeding (31.3% vs 14%) and major bleeding (5.6% vs 3.2%)[85].